Talis Biomedical Corp TLIS:NASDAQ

RT Quote | USD
Last | 05/21/24 EDT
8.85quote price arrow up+0.15 (+1.72%)
Volume
1,028
52 week range
4.35 - 9.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.70
  • 52 Week High9.60
  • 52 Week High Date05/07/24
  • 52 Week Low4.35
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap16.126M
  • Shares Out1.82M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change18.79

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.70
  • 52 Week High9.60
  • 52 Week High Date05/07/24
  • 52 Week Low4.35
  • 52 Week Low Date10/31/23
  • Market Cap16.126M
  • Shares Out1.82M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change18.79

RATIOS/PROFITABILITY

  • EPS (TTM)-34.19
  • P/E (TTM)-0.26
  • Fwd P/E (NTM)-0.41
  • EBITDA (TTM)-63.245M
  • ROE (TTM)-63.32%
  • Revenue (TTM)2.134M
  • Gross Margin (TTM)98.08%
  • Net Margin (TTM)-2,905.67%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Talis Biomedical Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Talis Biomedical Corporation is engaged in transforming diagnostic testing by developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions at the point of care. The Company is engaged in developing the Talis One system, a cloud-enabled molecular diagnostic platform. The Talis One system consists of compact instrument, single-use test cartridges and software that is designed to support a central cloud...
Robert Kelley
Chief Executive Officer, Director
Andrew Lukowiak Ph.D.
President, Chief Scientific Officer
Rebecca Markovich
Interim Chief Financial Officer
Address
1100 Island Drive, Suite 101
Redwood City, CA
94065
United States